Zambetti Benjamin R, Thomas Fridtjof, Hwang Inyong, Brown Allen C, Chumpia Mason, Ellis Robert T, Naik Darshan, Khouzam Rami N, Ibebuogu Uzoma N, Reed Guy L
Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
PLoS One. 2017 Jul 31;12(7):e0181658. doi: 10.1371/journal.pone.0181658. eCollection 2017.
In ST-elevation myocardial infarction (STEMI), acute kidney injury (AKI) may increase subsequent morbidity and mortality. Still, it remains difficult to predict AKI risk in these patients. We sought to 1) determine the frequency and clinical outcomes of AKI and, 2) develop, validate and compare a web-based tool for predicting AKI.
METHODS & FINDINGS: In a racially diverse series of 1144 consecutive STEMI patients, Stage 1 or greater AKI occurred in 12.9% and was severe (Stage 2-3) in 2.9%. AKI was associated with increased mortality (5.7-fold, unadjusted) and hospital stay (2.5-fold). AKI was associated with systolic dysfunction, increased left ventricular end-diastolic pressures, hypotension and intra-aortic balloon counterpulsation. A computational algorithm (UT-AKI) was derived and internally validated. It showed higher sensitivity and improved overall prediction for AKI (area under the curve 0.76) vs. other published indices. Higher UT-AKI scores were associated with more severe AKI, longer hospital stay and greater hospital mortality.
In a large, racially diverse cohort of STEMI patients, Stage 1 or greater AKI was relatively common and was associated with significant morbidity and mortality. A web-accessible, internally validated tool was developed with improved overall value for predicting AKI. By identifying patients at increased risk, this tool may help physicians tailor post-procedural diagnostic and therapeutic strategies after STEMI to reduce AKI and its associated morbidity and mortality.
在ST段抬高型心肌梗死(STEMI)中,急性肾损伤(AKI)可能会增加随后的发病率和死亡率。然而,预测这些患者的AKI风险仍然很困难。我们试图:1)确定AKI的发生率和临床结局,以及2)开发、验证并比较一种基于网络的AKI预测工具。
在1144例连续的不同种族STEMI患者中,1期或更严重的AKI发生率为12.9%,严重(2 - 3期)的发生率为2.9%。AKI与死亡率增加(未调整,5.7倍)和住院时间延长(2.5倍)相关。AKI与收缩功能障碍、左心室舒张末期压力增加、低血压和主动脉内球囊反搏有关。推导并内部验证了一种计算算法(UT - AKI)。与其他已发表的指标相比,它对AKI显示出更高的敏感性和更好的总体预测能力(曲线下面积为0.76)。UT - AKI得分越高,AKI越严重,住院时间越长,医院死亡率越高。
在一个大型、种族多样的STEMI患者队列中,1期或更严重的AKI相对常见,且与显著的发病率和死亡率相关。开发了一种可通过网络访问的、经过内部验证的工具,其在预测AKI方面具有更高的总体价值。通过识别风险增加的患者,该工具可能有助于医生调整STEMI后程序后的诊断和治疗策略,以降低AKI及其相关的发病率和死亡率。